Business Context and Reporting Period
Aurelion Inc., a foreign private issuer, filed a Form 6-K report for the month of April 2026, dated April 13, 2026. The filing serves as a current report to announce a change in senior management rather than to provide periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance updates and contains no financial statements or performance data.
Material Changes
The primary material change disclosed is the appointment of Ms. Yuki Xu as the acting Chief Accounting Officer, effective April 13, 2026. She replaces Ms. Hattie He, the previous Chief Accounting Officer.
Management Commentary and Risks
Management highlighted Ms. Xu's extensive background, including her role as Associate Director of Financial Reporting and Disclosure at Burning Rock Biotech Limited (Nasdaq: BNR) from 2019 to March 2026, where she oversaw U.S. GAAP financial statements and SEC reporting. Prior to that, she worked in the Audit Department at KPMG Huazhen LLP from 2014 to 2019. The filing notes that this information is incorporated by reference into the Company's registration statement on Form F-3. No specific risks, contingencies, or unusual items were disclosed in this text.
Investor Verification Checklist
- Verify the effective date of the leadership transition for the Chief Accounting Officer.
- Confirm the professional qualifications and prior experience of the new acting Chief Accounting Officer.
- Review the referenced Form F-3 (File No. 333-290953) for any updated financial data or risk factors incorporated by reference.
- Monitor future filings for the appointment of a permanent Chief Accounting Officer if the "acting" title is temporary.